Search

Your search keyword '"Gaia D."' showing total 44 results

Search Constraints

Start Over You searched for: Author "Gaia D." Remove constraint Author: "Gaia D."
44 results on '"Gaia D."'

Search Results

2. Correction: Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies (Critical Care, (2023), 27, 1, (3), 10.1186/s13054-022-04294-5)

3. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

4. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

6. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

9. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

11. C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect

14. Impact of Pre-existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures

15. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

16. Innovative Thermal Management Concepts for Sharp Leading Edges of Hypersonic Vehicles

18. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study

19. Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance: The IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study

21. Transdermal oestradiol replacement therapy enhances platelet constitutive nitric oxide synthase activity in postmenopausal women with type 2 diabetes mellitus

22. Hyperprolactinaemia and prolactin binding in benign intracranial tumours

23. Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg)

30. Effects of Octreotide Treatment on the Proliferation and Apoptotic Index of GH-Secreting Pituitary Adenomas

31. Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy

32. Mitral Valve-In-Valve: Defining the Indication Limits by in vitro Hydrodynamic Tests in a Brazilian Transcatheter Prosthesis.

33. First-in-Human Endo-Bentall Procedure for Simultaneous Treatment of the Ascending Aorta and Aortic Valve.

34. 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification.

35. Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures.

36. In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves.

37. Off-pump trans-apical trans-catheteraortic valve implantation: first successful case report in India.

39. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.

40. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status.

41. GH but not IGF-I hypersecretion in acromegaly is generally attenuated in elderly acromegalics.

42. Functioning and non-functioning pituitary adenomas in 173 adult and elderly patients.

43. Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas.

44. Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg).

Catalog

Books, media, physical & digital resources